close
MENU
Hot Topic NBR Focus: GMO
Hot Topic NBR Focus: GMO
3 mins to read

IPO won’t wait for FMA review, says Partners Life

Regulator begins analysis of four years of data in insurance churn probe.

Tim Hunter
Fri, 25 Sep 2015

Insurer Partners Life won’t wait for the outcome of a regulatory review into commissions and customer churn before an NZX float, says managing director Naomi Ballantyne.

The Financial Markets Authority has just finished collecting four years of data from life insurers as it investigates whether

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends July 31st

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Tim Hunter
Fri, 25 Sep 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
IPO won’t wait for FMA review, says Partners Life
51862
true